financetom
Business
financetom
/
Business
/
Vertex Insider Sold Shares Worth $954,541, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vertex Insider Sold Shares Worth $954,541, According to a Recent SEC Filing
Mar 12, 2024 1:48 PM

04:21 PM EDT, 03/12/2024 (MT Newswires) -- Bryan T.R. Rowland, General Counsel, on March 08, 2024, sold 32,196 shares in Vertex (VERX) for $954,541. Following the Form 4 filing with the SEC, Rowland has control over a total of 8,018 shares of the company, with 8,018 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1806837/000141588924007629/xslF345X03/form4-03122024_080352.xml

Price: 29.62, Change: -0.21, Percent Change: -0.7

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Analog Devices Insider Sold Shares Worth $2,663,640, According to a Recent SEC Filing
Analog Devices Insider Sold Shares Worth $2,663,640, According to a Recent SEC Filing
Mar 26, 2025
04:42 PM EDT, 03/26/2025 (MT Newswires) -- Vivek Jain, Executive Vice President, Global Operations, on March 24, 2025, sold 12,684 shares in Analog Devices ( ADI ) for $2,663,640. Following the Form 4 filing with the SEC, Jain has control over a total of 43,175 common shares of the company, with 43,175 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/6281/000000628125000088/xslF345X05/wk-form4_1743021114.xml ...
CRISPR Therapeutics COO to Step Down
CRISPR Therapeutics COO to Step Down
Mar 26, 2025
04:38 PM EDT, 03/26/2025 (MT Newswires) -- CRISPR Therapeutics ( CRSP ) said late Wednesday that Chief Operating Officer Julianne Bruno will be stepping down from the company to pursue external opportunities, effective April 11. ...
Guardian Pharmacy Services Reports Q4 Earnings as Revenue Increases
Guardian Pharmacy Services Reports Q4 Earnings as Revenue Increases
Mar 26, 2025
04:36 PM EDT, 03/26/2025 (MT Newswires) -- Guardian Pharmacy Services ( GRDN ) reported Q4 earnings Wednesday of $0.19 per diluted share. Three analysts polled by FactSet expected earnings of $0.22 per diluted share. The company completed its initial public offering in September 2024. Revenue for the quarter ended Dec. 31 was $338.6 million, up from $281.1 million a year...
Savara Files Biologics License Application to US FDA for Molbreevi to Treat Lung Disease
Savara Files Biologics License Application to US FDA for Molbreevi to Treat Lung Disease
Mar 26, 2025
04:44 PM EDT, 03/26/2025 (MT Newswires) -- Savara (SVRA) said late Wednesday it has completed submission of a biologics license application to the US Food and Drug Administration for Molbreevi to treat autoimmune pulmonary alveolar proteinosis, a rare lung disease. Savara requested priority review, which, if granted, will shorten the FDA's review to six months from the standard 10 months...
Copyright 2023-2026 - www.financetom.com All Rights Reserved